Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

Cited by (432)

Items 101–200 of 432

1. Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites
   Xiao-yan He, Jingtao Liang, Xin Li, Yao Wang, Xiaobo Zhang, Dayi Chen, Lijuan Wu, Shiyu Wang · 2023 · Journal of Ethnopharmacology
2. Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
   Yunkai Dai, Zhimin Zhao, Chenghai Liu · 2022 · Frontiers in Pharmacology
3. Loss of CEACAM1 in endothelial cells causes hepatic fibrosis
   Harrison T. Muturi, Hilda E. Ghadieh, Raziyeh Abdolahipour, Hannah L. Stankus, Getachew Debas Belew, James K. Liu, Marziyeh Salehi Jahromi, Abraham D. Lee, Bernhard B. Singer, Isabella Angeli‐Pahim et al. · 2023 · Metabolism
4. Hydrogel microneedle patch for treatment of liver fibrosis
   Xiangqian Gu, Zhaorong Wu, Duan Wu, Biao Hou, Linke Bian, Tao Zhou, Yuchen Hou, Hongye Wang, Zhigang Zheng · 2023 · Materials Today Advances
5. Seladelpar combined with complementary therapies improves fibrosis, inflammation, and liver injury in a mouse model of nonalcoholic steatohepatitis
   Yun‐Jung Choi, Jeff D. Johnson, Jin-Ju Lee, Jiangao Song, Marcy D. Matthews, Marc K. Hellerstein, Charles A. McWherter · 2023 · American Journal of Physiology-Gastrointestinal and Liver Physiology
6. Chinese consensus on the management of liver cirrhosis
   Chinese Society of Gastroenterology, Chinese Medical Association · 2024 · Journal of Digestive Diseases
7. Luteolin-7-diglucuronide, a novel PTP1B inhibitor, ameliorates hepatic stellate cell activation and liver fibrosis in mice
   Bixi Tang, Yong Zhang, Dandan Sun, Qinyi Liu, Cong Li, Peipei Wang, Lixin Gao, Xuemei Zhang, Jia Li, Weiliang Zhu et al. · 2024 · Acta Pharmacologica Sinica
8. Protective effects of puerarin on metabolic diseases: Emphasis on the therapeutical effects and the underlying molecular mechanisms.
   Qiang Wan, Sang Luo, Qi-Wen Lu, Cheng-Yan Guan, Hao Zhang, Zhiyan Deng · 2024 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
9. The role of artificial intelligence in the management of liver diseases
   Ming‐Ying Lu, Wan‐Long Chuang, Ming‐Lung Yu · 2024 · The Kaohsiung Journal of Medical Sciences
10. Fibrosis resolution in the mouse liver: Role of Mmp12 and potential role of calpain 1/2
    Sato, Toshifumi, Head, Kimberly Z., Li, Jiang, Dolin, Christine E., Wilkey, Daniel, Skirtich, Nolan, Smith, Katelyn, McCreary, Dylan D., Liu, Sylvia, Beier, Juliane I. et al. · 2023 · Matrix Biology Plus
11. Prospective therapeutics for intestinal and hepatic fibrosis
    Xin Li, Mengli Yu, Qingwei David Zhao, Yang Yu · 2023 · Bioengineering & Translational Medicine
12. Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1/STAT6-microRNA-23a feedback loop in macrophage M2 polarization
    Yanfeng Zheng, Shaoxiu Ji, Xia Li, Li Wen · 2023 · Biomedicine & Pharmacotherapy
13. Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis
    Zhen Li, Junfeng Zhu, Hao Ouyang · 2023 · Frontiers in Pharmacology
14. Gut microbial dysbiosis is associated with metabolism and immune factors in liver fibrosis mice
    Bing Zhao, Ye Jin, Meixin Shi, Ligen Yu, Guopeng Li, Wenjie Cai, Zhao‐Yang Lu, Can Wei · 2023 · International Journal of Biological Macromolecules
15. Raspberry Ketone Attenuates Hepatic Fibrogenesis and Inflammation via Regulating the Crosstalk of FXR and PGC-1α Signaling
    Yu-Chen Jiang, Jia-Yi Dou, Meiyan Xuan, Chong Gao, Zhaoxu Li, Li‐Hua Lian, Zhenyu Cui, Ji‐Xing Nan, Yan‐Ling Wu · 2024 · Journal of Agricultural and Food Chemistry
16. Association between triglyceride to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease and liver fibrosis in American adults: an observational study from the National Health and Nutrition Examination Survey 2017–2020
    Jianjun Wang, Han Li, Xiaoyi Wang, Ruizi Shi, Junchao Hu, Xintao Zeng, Hua Luo, Pei Yang, Huiwen Luo, Yuan Cao et al. · 2024 · Frontiers in Endocrinology
17. Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-β1/CUGBP1 and IFN-γ/Smad7 pathway
    Linmao Ye, Jiaxin Huang, Xiaofan Liang, Wenqin Guo, Xiguang Sun, Chang Shao, Yi He, Junjie Zhang · 2024 · Phytomedicine
18. Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis.
    Pasquale Rapacciuolo, C. Finamore, C. Di Giorgio, Bianca Fiorillo, Carmen Massa, G. Urbani, S. Marchianò, M. Bordoni, Chiara Cassiano, E. Morretta et al. · 2024 · Journal of Medicinal Chemistry
19. Reprogramming macrophages to treat liver diseases
    Blanca Simón-Codina, Júlia Cacho-Pujol, Anna Moles, Pedro Melgar‐Lesmes · 2024 · Hepatology
20. Targeted Activation of HNF4α/HGF1/FOXA2 Reverses Hepatic Fibrosis Via Exosome-Mediated Delivery of CRISPR/dCas9-SAM System
    Nianan Luo, Wenjun Zhong, Jiangbin Li, Zhongjie Zhai, Jianguo Lu, Rui Dong · 2022 · Nanomedicine
21. Therapeutic implications of obeticholic acid, a farnesoid X receptor agonist, in the treatment of liver fibrosis
    Azizsoltani, Arezou, Niknam, Bahare, Taghizadeh-Teymorloei, Mohammad, Ghoodjani, Erfan, Dianat-Moghadam, Hassan, Alizadeh, Effat · 2025 · Biomedicine & Pharmacotherapy
22. Dietary supplementation of pterostilbene, a major component in small berries, prevents alcohol-induced liver injury associated with lipid accumulation and inflammation
    Jia-Yi Dou, Sai-Hu Liu, Jia Guo, Chenyu Wang, Xu Dai, Li‐Hua Lian, Zhenyu Cui, Ji‐Xing Nan, Yan‐Ling Wu · 2024 · Food & Function
23. Indole-3-propionic acid promotes hepatic stellate cells inactivation
    Mariana Ilha, Ratika Sehgal, Johanna Matilainen, Kirsi J. Rilla, Dorota Kamińska, Shrey Gandhi, Ville Männistö, Charlotte Ling, Stefano Romeo, Päivi Pajukanta et al. · 2025 · Journal of Translational Medicine
24. Pericytes in tissue fibrosis
    Izabela Tuleta, Nikolaos Georgios Frangogiannis · 2025 · American Journal of Physiology-Cell Physiology
25. Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion
    Vu Ngoc Hieu, Lê Thị Thanh Thủy, Hoang Hai, Ninh Quoc Dat, Dinh Viet Hoang, Ngo Vinh Hanh, Dong Minh Phuong, Truong Huu Hoang, Hitomi Sawai, Yoshitsugu Shiro et al. · 2022 · Redox Biology
26. Neddylation of EphB1 Regulates Its Activity and Associates with Liver Fibrosis
    Rongxin Li, Dan Zhang, Yueqing Han, Ke Chen, Weiran Guo, Yijun Chen, Shuzhen Wang · 2023 · International Journal of Molecular Sciences
27. HOXC8/TGF-β1 positive feedback loop promotes liver fibrosis and hepatic stellate cell activation via activating Smad2/Smad3 signaling
    Ning Zhang, Fang Guo, Yuanyuan Song · 2023 · Biochemical and Biophysical Research Communications
28. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.
    Hong-Jian Lu, Rong-Hua Zhang, Shu-Kun Zhang, Yu-Feng Li, Yan-Kun Liu, Ya-Nan Xiong, Xiaohan Yu, Tao Lan, Xin Li, Mei-Mei Wang et al. · 2023 · International Immunopharmacology
29. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
    Li Xie, Hui Chen, Li Zhang, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yuli Wang, Yue Ma, Ya-Jun Yan, Jia Ding et al. · 2024 · Clinical and Molecular Hepatology
30. Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression
    Yuly Paulin Mendoza, Sofia Tsouka, Georg Semmler, Patcharamon Seubnooch, Katrin Freiburghaus, Mattias Mandorfer, Jaime Bosch, Mojgan Masoodi, Annalisa Berzigotti · 2024 · Journal of Hepatology
31. Pathological Microenvironment‐Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes‐Hepatic Stellate Cells Malignant Crosstalk
    Lingfeng Zhang, Wen‐Qi Deng, Xinghuan Wang, Qing‐Wen Huang, Su‐Qing Liang, Ze‐Quan Ding, Liang Qi, Yi Wang, Tian‐Jiao Zhou, Lei Xing et al. · 2024 · Advanced Science
32. Ampelopsis grossedentata tea alleviating liver fibrosis in BDL-induced mice via gut microbiota and metabolite modulation
    Yiyuan Xi, Chen Chen, Jujia Zheng, Bing‐Hua Jiang, Xin-Ya Dong, Shu-Ying Lou, Jin-Guo Luo, Xiu-Hua Zhang, Ziye Zhou, Qu-Jing Luo et al. · 2024 · npj Science of Food
33. Radiotracers for Imaging of Fibrosis: Advances during the Last Two Decades and Future Directions
    Olof Eriksson, Irina Velikyan · 2023 · Pharmaceuticals
34. Multi-omics and experimental analysis unveil the key components in Scutellaria baicalensis Georgi to alleviate hepatic fibrosis via regulating cPLA2-mediated arachidonic acid metabolism
    Yunheng Yang, Yi Liu, Honglin He, Honglin He, Ailing Liang, Zheng Pan, Yuanyuan Liu, Zhiwei Chen · 2024 · Journal of Translational Medicine
35. Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-β Signaling
    Ke Qian, Xiaohua Lei, Guoxing Liu, Yu Fang, Chengzhi Xie, Xiaolong Wu, Qiang Liu, Gao Liu, Zhenyu Cao, Ju Zhang et al. · 2022 · Disease Markers
36. Stress and Liver Fibrogenesis
    Zachary Hanquier, Jagannath Misra, Reese Baxter, Jessica L. Maiers · 2023 · American Journal Of Pathology
37. Tanshinone IIA regulates CCl4 induced liver fibrosis in C57BL/6J mice via the PI3K/Akt and Nrf2/HO‐1 signaling pathways
    Qingqing Li, Dongrui Huang, Wenjing Liao, Xinyue Su, Jin Li, Jinwei Zhang, Meng Fang, Yuwei Liu · 2024 · Journal of Biochemical and Molecular Toxicology
38. Notoginsenoside R1 targets PPAR-γ to inhibit hepatic stellate cell activation and ameliorates liver fibrosis
    Cheng Guo, Linying Lai, Boyu Ma, Qian Huang, Zhirong Wang · 2024 · Experimental Cell Research
39. Hydronidone induces apoptosis in activated hepatic stellate cells through endoplasmic reticulum stress‐associated mitochondrial apoptotic pathway
    Zhongshang Sun, Yuecheng Guo, Xianjun Xu, Cui Lan Zhou, Xin Luo, Zhenyang Shen, Bo Shen, Junjun Wang, Jingyi Lu, Qingqing Zhang et al. · 2024 · Journal of Gastroenterology and Hepatology
40. CD36 in liver diseases
    Yi Liu, Wenwei Yin · 2025 · Hepatology Communications
41. Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation
    Fangqing Zhao, Xuan Niu, Ge Song, Lijie Wang, Yiming Fu, Shuwen Li, Xinxin Gu, Qingkun Wang, Jiao Luo · 2025 · Journal of Translational Medicine
42. Spatial gene regulatory networks driving cell state transitions during human liver disease
    Nigel L. Hammond, Syed Murtuza Baker, Sokratia Georgaka, Ali Al-Anbaki, Elliot J. Jokl, Kara Simpson, Rosa Sánchez‐Alvarez, Varinder Singh Athwal, Huw Purssell, Ajith Kumar Siriwardena et al. · 2025 · EMBO Molecular Medicine
43. The future of hepatology
    Scott L. Friedman, Arun Jayant Sanyal · 2023 · Hepatology
44. Suaeda glauca Attenuates Liver Fibrosis in Mice by Inhibiting TGFβ1-Smad2/3 Signaling in Hepatic Stellate Cells
    You-Jung Hong, Gil-Hwan Kim, Y. R. Park, Hye‐Jin Jo, Min-Woo Nam, Dong‐Gu Kim, Hwangeui Cho, Hyun-Joo Shim, Jong‐Sik Jin, Hyunsoo Rho et al. · 2023 · Nutrients
45. Ginkgolic acid inhibits the expression of SAE1 and induces ferroptosis to exert an anti-hepatic fibrosis effect
    Sai Zhang, Zeyang Liu, Tong Xia, Wenjuan Hao, Ruining Yang, Jianghong Li, Gang Du, Qianqian Xu, Zhaochen Jiang, Mingkun Liu et al. · 2023 · Phytomedicine
46. Redox Biology and Liver Fibrosis
    Francesco Bellanti, Domenica Mangieri, Gianluigi Vendemiale · 2023 · International Journal of Molecular Sciences
47. Platelet-derived growth factor receptor β-targeted positron emission tomography imaging for the noninvasive monitoring of liver fibrosis
    Li Zhao, Hao Yang, Xin Li, Tianshan She, Ze Tao, Yi Zhong, Tao Su, Yanru Feng, Qiuxiao Shi, Lin Li et al. · 2024 · European Journal of Nuclear Medicine and Molecular Imaging
48. A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes
    Manvita Mareboina, Elen Deng, Ioannis Mouratidis, Nelson S. Yee, Nelly Pitteloud, Ilias Georgakopoulos‐Soares, Dionysios V. Chartoumpekis · 2024 · Molecular Metabolism
49. Melatonin Prevents Thioacetamide–Induced Gut Leakiness and Liver Fibrosis Through the Gut–Liver Axis via Modulating Sirt1‐Related Deacetylation of Gut Junctional Complex and Hepatic Proteins
    Wiramon Rungratanawanich, Karli R. LeFort, Young‐Eun Cho, Xiaoling Li, Byoung‐Joon Song · 2024 · Journal of Pineal Research
50. The structure elucidation and alleviating effect on liver fibrosis in vivo of a pectin-like polysaccharide isolated from Buddleja officinalis
    Jianing Zong, Yun Li, Wanqi Zhou, Mengfei Mao, Xin Xu, Simin Cai, Meixia Li, Kan Ding · 2024 · International Journal of Biological Macromolecules
51. Hypoxia-inducible factor-1 alpha (HIF-1α) inhibitor AMSP-30 m attenuates CCl4-induced liver fibrosis in mice by inhibiting the sonic hedgehog pathway
    Long‐Sheng Lu, Yuchen Ma, Qing Tao, Jing Xie, Xiao Liu, Yongkang Wu, Yang Zhang, Xiuli Xie, Mingming Liu, Yong Jin · 2025 · Chemico-Biological Interactions
52. Reviewing the function of macrophages in liver disease
    Lanlan Chen, Adrien Guillot, F. Tacke · 2025 · Expert Review of Gastroenterology & Hepatology
53. Edaravone protects against liver fibrosis progression via decreasing the IL-1β secretion of macrophages
    Rongrong Zhao, Huajun Zhao, Quanjuan Guo, Yongliang Mu, Jian Zhang, Yuhang Su, Qiuju Han · 2022 · Chemico-Biological Interactions
54. Kaempferol Alleviates Carbon Tetrachloride-Induced Liver Fibrosis in Mice by Regulating Intestinal Short-Chain Fatty Acids
    Siqi Zhang, Fei Tang, Zhe Zhou, Linhui Li, Yang Tang, Kaiwen Fu, Yang Tan, Ling Li · 2025 · International Journal of Molecular Sciences
55. TNC‑targeted CAR‑macrophage therapy alleviates liver fibrosis in mice
    Chen, Kai‑Zhao, Lin, Zi‑Yang, Chen, Long‑Jun, Zhou, You‑Xi, Zhang, Wei, Wan, Hao‑Yang, Huo, Yong‑Kun, Fu, Qi, Gao, Zi‑Qing, Cheng, Hong‑Wei et al. · 2025 · Military Medical Research
56. Cornus officinalis with high pressure wine steaming enhanced anti-hepatic fibrosis: Possible through SIRT3-AMPK axis
    Xin Han, Yan Ning, Xinyue Dou, Yiwen Wang, Qiyuan Shan, Kao Shi, Zeping Wang, Chuan Ding, Min Hao, Kuilong Wang et al. · 2023 · Journal of Pharmaceutical Analysis
57. Roles and therapeutic targeting of dendritic cells in liver fibrosis
    Bingyu Wang, Liuxin Yang, Xingxing Yuan, Yang Zhang · 2024 · Journal of drug targeting
58. MiR-4465-modified mesenchymal stem cell-derived small extracellular vesicles inhibit liver fibrosis development via targeting LOXL2 expression
    Wang, Yanjin, Chen, Yifei, Yang, Fuji, Yu, Xiaolong, Chu, Ying, Zhou, Jing, Yan, Yongmin, Xi, Jianbo · 2024 · Journal of Zhejiang University-SCIENCE B
59. Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Reversing Hepatic Fibrosis in 3D Liver Spheroids
    Giulia Chiabotto, Armina Semnani, Elena Ceccotti, Marco Guenza, Giovanni Camussi, Stefania Bruno · 2024 · Biomedicines
60. Lactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK/NF-κB signaling pathway through intestinal flora
    Zhu, Liping, Lv, Bo, Gao, Yuefeng, Qin, Dongmei · 2025 · Archives of Biochemistry and Biophysics
61. Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly
    Haohao Lu, Chuansheng Zheng, Bin Xiong, Xiangwen Xia · 2022 · BMC Gastroenterology
62. Role of follistatin-like protein 1 in liver diseases
    Chuansha Gu, Hua Xue, Xiaoli Yang, Yu Nie, Xinlai Qian · 2022 · Experimental Biology and Medicine
63. Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe
    Dabing Ping, Xin Sun, Yuan Yang Peng, Chenghai Liu · 2023 · Chinese Medicine
64. Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
    Lijun Chen, Ning Zhang, Yuqi Huang, Qi Zhang, Yangxin Fang, Jiamin Fu, Yin Yuan, Lu Chen, Xin Chen, Zhenyu Xu et al. · 2023 · Stem Cell Reviews and Reports
65. Metabolomics reveals that chronic restraint stress alleviates carbon tetrachloride-induced hepatic fibrosis through the INSR/PI3K/AKT/AMPK pathway
    Shanshan Zhang, Binjie Liu, Lan Huang, Rong Zhang, Lin An, Zhongqiu Liu · 2023 · Journal of Molecular Medicine
66. Recruitment of large peritoneal macrophages to capsular fibrosis developed on the liver surface
    Steven Balog, Soi Jeong, Kinji Asahina · 2023 · The FASEB Journal
67. Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells
    Yangfeng Lv, Chuan-Sheng Xie, Zhixing Liu, Mei‐diao Kang, Yue Liu, Zi-qiang Liao, Yu-long Ji, Rui Zhao, Yanshu Li, Xiao-yong Wei et al. · 2024 · Biochemical Pharmacology
68. Effects of Mesenchymal Stem Cells-Derived Extracellular Vesicles on Inhibition of Hepatic Fibrosis by Delivering miR-200a
    Ailei Xu, Long Han, Jun Yan, Dan Liu, Wei Wang · 2024 · Tissue Engineering and Regenerative Medicine
69. The intervention of curcumin on rodent models of hepatic fibrosis: A systematic review and meta-analysis
    Yunhang Chu, Bing-Yao Pang, Ming Yang, Qi Meng, Yan Leng · 2024 · PLoS ONE
70. Wedelolactone Attenuates Liver Fibrosis and Hepatic Stellate Cell Activation by Suppressing the Hippo Pathway
    Wei Zhang, Kai Gao, Ya Bai, Dong Xu, Meina Zhao, Xingru Tao, Jingwen Wang · 2024 · Rejuvenation Research
71. Exploring the mechanism of ursolic acid in preventing liver fibrosis and improving intestinal microbiota based on NOX2/NLRP3 inflammasome signaling pathway
    Qi Liu, Lin-Xiang Liu, Bimin Li, Wang Zhang, Yue Zhang, Peng Chen, Chenkai Huang, Yuan Nie, Xuan Zhu · 2024 · Chemico-Biological Interactions
72. Extracellular Vesicles in Viral Liver Diseases
    Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki · 2024 · Viruses
73. Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI
    Valeria Carnazzo, Stefano Pignalosa, Marzia Tagliaferro, Laura Gragnani, Anna Linda Zignego, Cosimo Racco, Luigi Di Biase, Valerio Basile, Gian Ludovico Rapaccini, Riccardo Di Santo et al. · 2024 · Clinical Biochemistry
74. Vincamine ameliorates hepatic fibrosis via inhibiting S100A4‐mediated farnesoid X receptor activation: based on liver microenvironment and enterohepatic circulation dependence
    Yu‐Chen Jiang, Jia Guo, Sai‐Hu Liu, Xu Dai, Chenyu Wang, Li‐Hua Lian, Zhenyu Cui, Ji‐Xing Nan, Yan‐Ling Wu · 2025 · British Journal of Pharmacology
75. Noninvasive Evaluation of Prolonged‐Release Pirfenidone in Compensated Liver Cirrhosis. <scp>ODISEA</scp> Study, a Randomised Trial
    Muñoz‐Espinosa, Linda E., Torre, Aldo, Cisneros, Laura, Montalvo, Iaarah, Malé, René, Mejía, Scherezada, Aguilar, Juan Ramón, Lizardi, Javier, Zuñiga‐Noriega, Jaime, Eugenia Icaza, María et al. · 2025 · Liver International
76. Immunological factors in cirrhosis diseases from a bibliometric point of view
    Dan Zhang, Bowen Liu, Xiao-Qing Liang, Fuquan Liu · 2023 · World Journal of Gastroenterology
77. Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
    Xiaofeng Chen, Yumei Wang, Shaoxiu Ji, Xin Sun, Quansheng Feng, Yu Han, Chao Liu · 2022 · Frontiers in Pharmacology
78. Live-cell imaging of human liver fibrosis using hepatic micro-organoids
    Guan, Yuan, Fang, Zhuoqing, Hu, Angelina, Roberts, Sarah, Wang, Meiyue, Ren, Wenlong, Johansson, Patrik K., Heilshorn, Sarah C., Enejder, Annika, Peltz, Gary · 2025 · JCI Insight
79. TIMP-1 Promotes Expression of MCP-1 and Macrophage Migration by Inducing Fli-1 in Experimental Liver Fibrosis
    Xiaoli Huang, Xiao-Fan Wang, Yanhong Wang, Shuangjun Shen, Wei Chen, Tianhui Liu, Ping Wang, Xu Fan, Lin Liu, Ji-dong Jia et al. · 2024 · Journal of Clinical and Translational Hepatology
80. Noncoding RNA network crosstalk in organ fibrosis
    Hui Ling, Xian-Chen Wang, Zhiyan Liu, Sui Mao, Jingjing Yang, Ji-Ming Sha, Hui Tao · 2024 · Cellular Signalling
81. Ginsenoside compound K restrains hepatic fibrotic response by dual-inhibition of GLS1 and LDHA
    Wenhui Wu, Yalan Yang, Ting Wang, Xiaomeng Sun, Meng‐Guang Wei, Xin-Yue Zhou, Li-Zeng Zhu, Gaoxiang Ma, Baolin Liu, Lian‐Wen Qi et al. · 2024 · Phytomedicine
82. Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
    Antonio Liguori, Giorgio Esposto, Maria Elena Ainora, Irene Mignini, Raffaele Borriello, Linda Galasso, Mattia Paratore, Maria Cristina Giustiniani, Laura Riccardi, Matteo Garcovich et al. · 2025 · Biomedicines
83. PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation
    Chittampalli N. Yashaswini, Bogdan Mitran, Natalia Papadopoulos, Olivia Wegrzyniak, John Löfblom, Helena Nordström, Irina Velikyan, Ayman Abouzayed, Lars Johansson, Per Hagmar et al. · 2025 · EJNMMI Radiopharmacy and Chemistry
84. Mesencephalic astrocyte‐derived neurotrophic factor alleviates non‐alcoholic steatohepatitis induced by Western diet in mice
    Jiamin Yan, Qinhui Liu, Qin Tang, Jinhang Zhang, Xiandan Jing, Yan Xia, Ying Xu, Jiahui Li, Yanping Li, Jinhan He · 2022 · The FASEB Journal
85. CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Nianan Luo, Wenjun Zhong, Jiangbin Li, Jianguo Lu, Rui Dong · 2022 · Molecular Biology Reports
86. Bibliometric-analysis visualization and review of non-invasive methods for monitoring and managing the portal hypertension
    Xiaohan Sun, Hongbo Ni, Jian Xue, Shuai Wang, Afaf Aljbri, Liuchun Wang, Tian Hang Ren, Xiao Li, Meng Niu · 2022 · Frontiers in Medicine
87. Gypenosides Synergistically Reduce the Extracellular Matrix of Hepatic Stellate Cells and Ameliorate Hepatic Fibrosis in Mice
    Han Li, Hanghang Wang, Aiping Yang, Mingzhen Xue, Junyang Wang, Qi Lv, Jian Liu, Lihong Hu, Yinan Zhang, Xiachang Wang · 2023 · Molecules
88. Integrated analysis and validation of TRIM23/p53 signaling pathway in hepatic stellate cells ferroptosis and liver fibrosis
    Jie Chen, Rui Zhang, Feng Li, Shengli Lin, Jian Wang · 2023 · Digestive and Liver Disease
89. Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells
    Rajani Kandhi, Alfredo Menéndez, Sheela Ramanathan, Subburaj Ilangumaran · 2023 · Journal of Clinical and Experimental Hepatology
90. TMT-based proteomics analysis identifies the interventional mechanisms of Qijia Rougan decoction in improving hepatic fibrosis
    Xiaofeng Chen, Xin Sun, Shaoxiu Ji, Han Yu, Peijie Wu · 2023 · Journal of Ethnopharmacology
91. Store-Operated Ca 2+ Entry in Fibrosis and Tissue Remodeling
    Ahmed Emam Abdelnaby, Mohamed Trebak · 2024 · Contact
92. Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway
    Yan Xue, Wanchun Zhu, Fengjie Qiao, Yilan Yang, Jiaohao Qiu, Chen Zou, Yating Gao, Xin Zhang, Man Li, Zhi Shang et al. · 2024 · Journal of Ethnopharmacology
93. Melanin inspired microcapsules delivering immune metabolites for hepatic fibrosis management
    Xin Zhao, Zun Fan, Chengyang Zhu, Weigang Zhang, Lei Qin · 2023 · Materials Today Bio
94. Discovery and development of benzene sulfonamide derivatives as anti-hepatic fibrosis agents
    Weiping Niu, Mei Zhu, Minghua Wang, Chenghong Zheng, Chenghong Zheng, Yunyang Bao, Yiming Li, Na Zhang, Juxian Wang, Hongwei He et al. · 2023 · Bioorganic & Medicinal Chemistry Letters
95. γδ T cells: The potential role in liver disease and implications for cancer immunotherapy
    He Ren, WanJing Li, Xin Liu, Na Zhao · 2022 · Journal of Leukocyte Biology
96. Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells
    Luyao Zhang, Min Tao, Hengyan Zhang, Shichao Zhang, Xiaojuan Hou, Chen Zong, Gangqi Sun, Shiyao Feng, Haixin Yan, Ying Lü et al. · 2024 · Chemico-Biological Interactions
97. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
    Jinyu Zhao, Ping Yue, Ningning Mi, Matu Li, Wenkang Fu, Xianzhuo Zhang, Long Gao, Mingzhen Bai, Liang Tian, Ningzu Jiang et al. · 2024 · Medical Review
98. Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic Potential
    Han Chen, Ying-Yi Li, Kouki Nio, Hong Tang · 2024 · Biomolecules
99. A herbal product inhibits carbon tetrachloride-induced liver fibrosis by suppressing the epidermal growth factor receptor signaling pathway
    Jingshu Qi, Dabing Ping, Xin Sun, Kai Huang, Yuan Yang Peng, Chenghai Liu · 2023 · Journal of Ethnopharmacology
100. Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor
     Kexin Zheng, Shouli Yuan, Meng Dong, Hanlin Zhang, Xiaoxiao Jiang, Chunlong Yan, Rongcai Ye, Huiqiao Zhou, Li Chen, Rui Jiang et al. · 2023 · World Journal of Gastroenterology